Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Defining the HER2 Positive (+) Breast Cancer Kinome Response to Trastuzumab, Pertuzumab, Combination Trastuzumab +Pertuzumab, or Combination Trastuzumab + Lapatinib

UNC Lineberger Comprehensive Cancer Center · 2013
ClinicalTrials.gov · Datasets · License: Public Domain · 2013
Open Source ↗
breast-cancerbreast-neoplasms
breast neoplasms, breast cancer, kinome, her two positive, interventional, early_phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1032325
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.